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Abstract
Background: Little is known about the natural history of human papillomavirus (HPV) infection
in Asian women.
Methods: A follow-up study was conducted, with exfoliated cervicovaginal cells self-collected
from, and questionnaires administered to 197 female students, aged 17–26 years, who had been
already examined one and half years before. The presence of 25 HPV types was evaluated by a
polymerase chain reaction-based assay.
Results: The acquisition of new infection for any HPV type among 171 female students at risk who
were negative at baseline, 60% of whom had remained as virgins, was 17.5% (95% confidence
interval [CI]: 11.8–23.2). Among individual types, HPV16, 18 and 35 showed the highest rate of new
infection. Women who had had first sexual intercourse (OR = 2.9; 95% CI: 1.0–8.8), or had changed
sexual partners (OR = 2.9; 95% CI: 0.9–9.3) during the follow-up period showed a higher risk of
new HPV infection than women who had remained virgins since baseline. The rate of new infection
also tended to be higher in those who started, or continued smoking during the follow-up period,
than in nonsmokers. Clearance of HPV infections since baseline examination was 80.6% (95% CI:
67.6–93.5), and did not differ between high-risk and low-risk HPV types or between single- and
multiple-type infections.
Conclusion: This study shows that the acquisition of new HPV infection among young women in
the Republic of Korea is high and also the clearance is frequent. Self-collection of cervicovaginal
cells is applicable to follow-up studies that include virgins.
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Background
More than half of sexually active women worldwide are
infected by one or more genital human papillomavirus
(HPV) types at some point in time [1], and the three-year
cumulative incidence of HPV infection among young
women in some Western countries is over 40% [2-4].
Although HPV infection is very common, 50% to 77% of
HPV-positive women in cohort studies have been shown
to clear the infection spontaneously in one year's time
[1,2,5-8]. No studies, however, have investigated type-
specific HPV incidence and clearance in Asian women.
Hence, we followed up a group of female students in
Busan, Republic of Korea, who had been evaluated for
HPV prevalence one and a half years earlier [9].
Methods
Study design and participants
In 2002, The Korean National Cancer Center conducted a
survey of HPV prevalence among female students in
Busan. The study design has been described in detail pre-
viously [9]. Briefly, 672 female students from three differ-
ent educational settings between 16 and 25 years of age
participated, and provided self-collected samples of cervi-
covaginal cells in the first HPV prevalence survey in 2002.
The HPV results would not be given to each participant
due to the inability to provide a therapeutic agent in the
case of positive results. About one and half years later, we
mailed and/or made telephone calls to these same stu-
dents, inviting them for a second examination.
To those who agreed, we mailed a package that contained
an informed consent form, a self-administered question-
naire, instructions for self-collection of cervicovaginal
cells in their home, and a self-collection kit (two Dacron
swabs and a tube containing buffered methanol). The
questionnaire requested information on changes in smok-
ing and sexual habits since baseline examination. After
three weeks, we made reminder calls to those who had not
responded, and repeated the call once a week for three
weeks, or until a response was obtained. We failed to con-
tact 291 (43%) students due to changes in address or tel-
ephone number. Among the 381 students contacted, 19
(3%) refused to participate in the follow-up study, and
165 (25%) did not return the questionnaire and speci-
men. A total of 197 (29%) students sent back the ques-
tionnaire and cell sample. The median time interval
between baseline and follow-up was 18.1 months (range:
17.1–19.7 months). All participants signed informed con-
sent forms according to the recommendation of the
Korean National Cancer Center Ethical Review Commit-
tee, which approved the study.
Specimen collection
The students collected the cell samples themselves in the
same way they had done at baseline [9]. They were asked
to bend their legs and to introduce and gently rotate a
Dacron swab (two swabs at follow-up, Medical Packing,
CA, USA) in the vagina until reaching the cervix and to
then place the swabs in a tube that contained 20 mL of
buffered methanol (PreservCyt Soultion, Cytyc, MA, USA)
without contaminating them. The specimens were stored
at room temperature and delivered to the laboratory,
where they were centrifuged at 3,000 × g, and the resulting
pellets stored at -70°C until needed for HPV DNA testing.
HPV testing
The method used for HPV testing was identical to that
used at baseline [9]. Briefly, HPV DNA was isolated from
the cytology specimen (MagNaPure Total Nucleic Acid
system, Roche Diagnostics, Almere, Netherlands) and was
amplified by use of a short PCR fragment (SPF)10 primer
set. Amplification products first were tested by probe
hybridization in a microtiter-plate assay (DEIA version 1)
for the presence of HPV DNA. SPF10 amplimers from HPV-
positive samples were subsequently analyzed by reverse
hybridization in an HPV line-probe assay (LiPA Kit HPV
INNO LiPA HPV genotyping assay, SPF-10 system version
1, Innogenetics, Gent, Belgium, manufactured by Labo
Bio-medical Products, Rijswijk, Netherlands). PCR prod-
ucts hybridized, at high stringency, to these probes, gener-
ating a type-specific hybridization pattern. The HPV LiPA
permits specific detection of 25 HPV types: HPV 6, 11, 16,
18, 31, 33–35, 39, 40, 42–45, 51–54, 56, 58, 59, 66, 68/
73, 70, and 74. HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56,
58, 59, 66, and 68/73 were considered high-risk types,
and all the other were considered low-risk types. Samples
that were SPF10-positive by DEIA but could not be identi-
fied by the type-specific oligonucleotide probes (LiPA)
were classified as HPV X (undetermined HPV types) and
categorized as low-risk types.
Statistical analysis
The Pearson chi-square test and student T-test were used
to compare data from participants and non-participants
to the follow-up with respect to social and behavioral
characteristics. We estimated the proportion of acquisi-
tion of new infection with specific HPV type(s) by calcu-
lation on the basis of the number of cases in which a given
type was detected in woman whom that the correspond-
ing type had not been detected at baseline. Infections were
also classified as high-risk or low-risk HPV type infections
[10]. Women infected with multiple-type infections that
included one or more high-risk type were classified as
high-risk infections. We used unconditional logistic
regression to calculate odds ratios (ORs) and correspond-
ing 95% confidence intervals (CIs) of new HPV infections
by changes of sexual behavior and cigarette smoking. All
analyses were conducted using STATA (version 9.0; Stata-
Corp).BMC Infectious Diseases 2008, 8:13 http://www.biomedcentral.com/1471-2334/8/13
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Results
Table 1 shows the comparison of social and behavioral
characteristics between participants and non-participants
to the follow-up. There were no significant differences in
mean age, smoking habits, alcohol drinking, sexual inter-
course and HPV-positivity between two groups.
Among 197 students who participated in the follow-up
study, 26 (13.2%) were positive for HPV DNA at baseline.
Table 2 shows the acquisition of new HPV infection by
type(s) among students at risk who were HPV-negative for
the corresponding type(s) at baseline. New infection with
any type of HPV was observed in 30 women (17.5%) one
and half years later. Acquisition of new infections was
highest for HPV 16, X, 18 and 35.
Table 3 shows the new HPV infections by changes in sex-
ual behavior or smoking habit. After adjustment for age,
the incidence of infection was higher in students who had
had first intercourse (OR = 2.9; 95% CI: 1.0–8.8) or had
changed sexual partner (OR = 2.9; 95% CI: 0.9–9.3) dur-
ing the follow-up period compared to those who had
remained virgins since baseline, although the associations
were borderline statistical significance. After adjustment
for age and for changes in sexual habits, the incidence of
infection was also higher in those who started (OR = 6.1;
95% CI: 0.9–40.8) smoking during the follow-up period
than in nonsmokers.
Table 4 shows clearance of HPV infections by type and
multiplicity. Out of 36 HPV infections with 17 different
HPV types or HPV X detected at baseline in 26 students,
80.6% were cleared at follow-up, one and half years later.
Clearance was not statistically different between low- and
high-risk HPV types, or single- and multiple-type infec-
tions, though the number of cases was limited. If the 26
HPV-positive women are used as a denominator, 26.9%
(7/26) became HPV-negative, 50.0% (13/26) cleared their
baseline infection(s) but acquired new HPV types, and
23.1% (6/26) remained positive for the same HPV type(s)
as at baseline (including three students with persistent
HPV X infection) (data not shown).
Discussion
The prevalence of HPV infection in female students in
Busan, Korea, at baseline was 15.2% [9]. In the follow-up
study, 17.5% of 171 students at risk who were HPV-nega-
tive at baseline became positive. Reinfection with a new
HPV type was also frequent (50% of 26 HPV-positive stu-
dents). The acquisition of new HPV infections was
approximately 30% in women who became sexually
active or changed sexual partner during the follow-up
period. Interestingly, 13% of the 118 students who
reported that they never had penetrative sexual inter-
course became HPV-positive at follow-up. Modes of HPV
transmission, besides penetrative sexual intercourse, have
been suggested [4,11], but, although the questionnaire
was self-administered and full confidentiality was
assured, we cannot rule out inaccuracies in the reporting
of sexual behavior. In addition, there may be a possibility
to be contaminated or false positive for HPV test of the
samples with never having a penetrative sexual inter-
course, even though it is very little or rare.
Acquisition of new HPV infection is common, particularly
among sexually active young women, and the incidence
appears to be higher for oncogenic than for non-onco-
genic types [6,12]. A prospective study in Brazilian
women showed that there were 1.3% new infections per
month, with 38% cumulative positivity after one and a
half years [5]. In Canadian university students, the inci-
dence rate was 1.9% per month, and the cumulative rate
was 18.0% at one year and 36.4% at two years of follow-
up [12]. In another study of Canadian women, the overall
infection incidence was 11.1% per year, with the highest
rate (25.0%) in the 15–19-year age group [8]. The rate of
new HPV infections in young women in the United States
was 2.9% per month [6], and the three-year cumulative
incidence was over 40% [2-4,11]. In our study, the rate of
acquisition of new infections for any HPV type per 1000
woman-months was estimated as 9.8 (95% CI: 6.6–14.0)
(data not shown). Considering the longer follow-up inter-
val than other studies, this study suggests that HPV inci-
dence in Korean female students is relatively lower than
that in corresponding populations in Western countries.
Table 1: Comparison of selective characteristics at baseline between groups of participants and nonparticipants to the follow-up.
Characteristics Nonparticipants Participants P-value
Age (mean) 18.4 Year 18.5 Year 0.366
Smoking 26% 18% 0.062
Alcohol drinking 47% 51% 0.867
Age at menarche (mean) 13.3 Year 13.2 Year 0.199
Sexual intercourse 26% 21% 0.066
Age at first sexual intercourse (mean) 18.3 Year 17.9 Year 0.326
Lifetime multiple sexual partners 13% 12% 0.295
HPV positive 16% 13% 0.381BMC Infectious Diseases 2008, 8:13 http://www.biomedcentral.com/1471-2334/8/13
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Current knowledge on the relationship between smoking
and incidence of HPV infection is limited, with previous
studies reporting inconsistent results [11,13,14]. In our
baseline study, smoking was one of the strongest risk fac-
tors for HPV-positivity in female students (ever-smokers
vs. never-smokers, OR = 3.8; 95% CI: 1.9–7.5) [9]. In cur-
Table 3: New infection of human papillomavirus (HPV) among 171 HPV-negative female students according to changes in sexual or 
smoking habits between baseline and follow-up. Busan, Korea
Baseline Follow-up No. of women New infection (%) OR (95% CI)
Sexual intercourse
No No 118 15 (12.7) 1.0
No Yes 20 6 (30.0) 2.9 (1.0–8.8)
Yes Yes, same partner 7 1 (14.3) 1.1 (0.1–10.3)
Yes Yes, new partner 17 5 (29.4) 2.9 (0.9–9.3)
Not reported Yes 9 3 (33.3) 3.4 (0.8–15.2)
Current smoking*
No No 131 16 (12.2) 1.0
No Yes 6 3 (50.0) 6.1 (0.9–40.9)
Yes Yes/No 12 5 (41.7) 3.3 (0.7–14.6)
Not reported 22 6 (27.3) 2.8 (0.9–8.4)
* ORs for changes in sexual habits were adjusted for the two age groups (years of 15–18 and 19–24); ORs for changes in smoking habits were 
adjusted for the two age groups and the five different categories of changes in sexual habits. OR: odds ratio; CI: confidence interval.
Table 2: Acquisition of new human papillomavirus (HPV) infection during one and half years, in female students negative for the 
corresponding HPV type(s). Busan, Korea
HPV type No. of women at risk 
(HPV-negative at baseline)
No. of new Infections at follow-up Acquisition of new infection, % (95% CI)
High-risk
16 195 17 8.7
18 196 8 4.1
31 195 3 1.5
33 196 1 0.5
35 197 6 3.0
39 196 2 1.0
45 197 0 0.0
51 190 1 0.5
52 195 4 2.1
56 196 0 0.0
58 196 2 1.0
59 196 2 1.0
66 196 2 1.0
68 194 2 1.0
Overall HR 181 23 12.7 (7.9–17.6)
Low-risk
61 9 7 4 2 . 0
11 196 0 0.0
34 197 0 0.0
40 197 0 0.0
42 197 0 0.0
43 197 2 1.0
44 197 1 0.5
53 196 1 0.5
54 196 3 1.5
70 196 0 0.0
74 195 1 0.5
X 190 13 6.8
Overall LR 187 15 8.0 (4.1–11.9)
Any type 171 30 17.5 (11.8–23.2)
X: undetermined HPV type; CI: confidence interval; HR: high-risk; LR: low-risk.BMC Infectious Diseases 2008, 8:13 http://www.biomedcentral.com/1471-2334/8/13
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rent follow-up study, smoking was again a predictor of
HPV incidence, although, after adjustment for changes in
sexual habits, the association was not statistically signifi-
cant. Moreover, clearance of HPV infection was more fre-
quent in women who never smoked than in women who
ever smoked, but the association was not statistically sig-
nificant (data not shown).
HPV infection is common, but it is highly transient. In our
study, 80% of infections cleared and 77% of students who
were HPV-positive at baseline became negative for the
HPV type(s) present at baseline after one and a half years.
Other studies also showed that the majority of HPV infec-
tions clear after one or two years [2,5-8,12,15]. In a popu-
lation-based five-year follow-up study in Colombian
women, 77% of HPV infections cleared after one year and
93% cleared after five years; clearance was most frequent
in the first six months of follow-up [7]. Other cohort stud-
ies also show 50%–75% clearance of HPV infections after
one year [2,5,6,8].
A self-collected Dacron swab sample of cervicovaginal
cells is a technically feasible alternative to clinician-
administered cervical cell collection in natural history
studies of HPV and cervical cancer [16]. Our previous
study, the baseline study, also showed that almost self-
collected cervicovaginal samples were very adequate for
test (β-globin positive in 99.1% of female students) [9].
Our current study has strengths and weaknesses. It is the
first study to apply self-collection of cervico-vaginal cells
and a very sensitive HPV testing method in a follow-up
study that included many virgins, and to show high rate of
acquisition of new HPV infection in young Asian women.
The HPV testing method that we used at baseline and also
at follow-up was highly sensitive but there could be unde-
tected infections. New infections could be infections that
were previously there and were missed, and cleared infec-
tions could be due to errors in the follow-up sample.
However, these limitations are also important in this
study as other studies.
Unfortunately, despite repeated efforts, traceability and
compliance among female students was low. Only 57%
(381/671) of female students were available to contact
and 52% (197/381) of those who contacted, participated
this study. Furthermore, there were only 36 baseline infec-
tions available for the analysis of clearance. Thus, there
was limitation to detect significant associations between
risk factors and HPV acquisition or clearance. However,
when we compared the characteristics (i.e., age, HPV pos-
itivity, sexual, smoking and alcohol drinking habits at
baseline) of study subjects who were and were not
included in the follow-up study, they did not differ signif-
icantly (Table 1). Moreover, based on the Korean
National Health and Nutrition Survey and other studies
[17,18], the health behaviors (i.e., smoking and alcohol
drinking habits and sexual intercourse) of study partici-
pants were similar to those of any other Korean girls of
these ages. Therefore our present findings on HPV acqui-
sition and clearance are not highly biased.
Conclusion
In summary, we investigated acquisition and clearance of
HPV infection with 197 followed-up female students in
Busan, Korea. This study shows that the acquisition of
new HPV infection among young women in the Republic
of Korea was high and also the clearance was frequent.
Self-collection of cervicovaginal cells is applicable to fol-
low-up studies that include virgins.
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